Clinical Trials on Malignant Neoplasm of Brain in Portugal

Total 167 results

European Organisation for Research and Treatment...

Active, not recruiting

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma (INNOVATION)

Malignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein Overexpression

Spain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
Thomas Zilli

Active, not recruiting

Hypofractionated Radiation Therapy in Prostate Cancer

Malignant Neoplasm of Prostate | Local Disease

Netherlands, Israel, Switzerland, Spain, Belgium, Finland, Portugal, Turkey
Hospices Civils de Lyon

Recruiting

Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma

Peritoneal Malignant Mesothelioma

Belgium, Portugal, France, Germany, India, Norway
Centro Hospitalar de Lisboa Central

Not yet recruiting

Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease.

Parkinson Disease | Botulinum Toxin | Freezing of Gate

Portugal
Novartis Pharmaceuticals

Completed

Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Malignant Melanoma

Portugal
Universidade da Madeira

Recruiting

Development and Application of a Musical Game for Motor Rehabilitation

Health People | Survivors of Stroke

Portugal
Umbria Bioengineering Technologies
Toscana Life Sciences Sviluppo s.r.l.; London South Bank University; ELAROS 24... and other collaborators

Recruiting

A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection

Women's Health: Neoplasm of Breast

Italy, Spain, Portugal, Poland, Switzerland
Instituto de Investigación Hospital Universitario...
Hospital de Santa Maria, Portugal

Completed

Thymoglobulin in Cadaver Donor

Prevention of Kidney Injury Associated With Brain Death

Spain, Portugal
Fundacao Champalimaud

Unknown

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Adenocarcinoma of the Prostate

Portugal
Universidade Nova de Lisboa
Fundação para a Ciência e a Tecnologia; Hospital Cuf Descobertas

Recruiting

Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients

Lung Cancer | Malignancy

Portugal
João Firmino Domingues Barbosa Machado
Universidade do Porto

Completed

Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer (SCAN-CC)

Reminder Systems | Uterine Cervical Neoplasm | Mass Screening | Early Detection of Cancer | Text Message

Portugal
Hospital Pedro Hispano
Diogo Melo Pinto, MD, Hospital Pedro Hispano; Telma Fonseca, MD, Centro Hospitalar... and other collaborators

Completed

Evaluation of cfDNA as a Marker of Response in Rectal Cancer

Cancer of Rectum

Portugal
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Epilepsy

Portugal
Hoffmann-La Roche

Completed

A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Malignant Melanoma, Neoplasms

Spain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
MedSIR
Daiichi Sankyo, Inc.

Completed

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease (DEBBRAH)

Advanced Breast Cancer | HER2-positive Breast Cancer | Brain Metastases | Leptomeningeal Metastasis

Spain, Portugal
Campus Neurológico Sénior

Completed

Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease

Parkinson Disease

Portugal
Associacao de Investigacao de Cuidados de Suporte...
Centro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; University...

Completed

Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors (MamaMoveGaia)

Quality of Life | Breast Cancer | Physical Exercise

Portugal
University Fernando Pessoa

Recruiting

ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS. (PACCO)

HSIL, High Grade Squamous Intraepithelial Lesions | AIN3 | AIN2

Portugal
Universidade do Porto
Instituto Portugues de Oncologia, Francisco Gentil, Porto; Unidade de Saúde... and other collaborators

Recruiting

HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme (HERSELF)

Papillomavirus Infections | Cervix Cancer | Early Detection of Cancer | Self-Examination

Portugal
Campus Neurológico Sénior
Johns Hopkins University

Completed

The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients

Parkinson Disease

Portugal
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention (DietINT)

Cancer of Head and Neck

Austria, Slovenia, Germany, Italy, Poland, Portugal
Hospices Civils de Lyon

Recruiting

QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management

Solid Tumor | Hematologic Cancer

Netherlands, France, Portugal, Spain
University of Minho
Foundation for Science and Technology, Portugal

Completed

Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life

Breast Cancer Female

Portugal
Campus Neurológico Sénior
University of Lisbon

Completed

Feasibility of the AHA Exergame System in Parkinson's Disease Patients

Parkinson Disease

Portugal
European Organisation for Research and Treatment...

Terminated

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

Gastric Cancer | Adenocarcinoma of the Gastroesophageal Junction

Belgium, Portugal, Germany
Albino Maia
Centro Hospitalar Lisboa Ocidental; Centro Hospitalar De São João, E.P.E.; Centro... and other collaborators

Recruiting

Deep Brain Stimulation-Induced Mania in Parkinson's Disease (BPD_DBS)

Parkinson Disease | Mania

Portugal
Instituto de Saude Publica da Universidade do Porto
IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade... and other collaborators

Recruiting

COVID-19: A Scope Research on Epidemiology and Clinical Course (COVID-Scope)

Covid19 | SARS CoV 2 Infection | Sequelae of; Infection

Portugal
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
Associacao de Investigacao de Cuidados de Suporte...
Centro Hospitalar de Vila Nova de Gaia/Espinho; Aveiro University; University... and other collaborators

Recruiting

Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial (FIT4TREAT)

Head and Neck Neoplasms

Portugal
Bial - Portela C S.A.

Active, not recruiting

OpicApone Sleep dISorder (OASIS)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of Food on BIA 6-512 (Trans-resveratrol)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. (BIPARKII)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Bayer

Completed

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors (POR-BetaPlus)

Secondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Parkinson's Disease (PD)

Portugal
Bial - Portela C S.A.

Completed

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Parkinson's Disease

Portugal, Romania, Ukraine
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
University Ghent
Universidade Nova de Lisboa; Horizon 2020 - European Commission; Hospital de... and other collaborators

Recruiting

ELEVATE Acceptability Study (ELEVATE AS)

Cervical Cancer | HPV Infection | Acceptability of Health Care

Belgium, Brazil, Ecuador, Portugal

Clinical Trials on Malignant Neoplasm of Brain in Portugal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations